Alexion Pharmaceuticals revenue

Alexion Pharmaceuticals revenue increased from $3.6 billion in 2017 to $4.1 billion in 2018, a 16.3% increase.

Annual Revenue ($)

Alexion Pharmaceuticals revenue was $4.13 b in FY, 2018

Quarterly Revenue ($)

FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$540.96 m$783.43 m$1.13 b$1.55 b$2.23 b$2.60 b$3.08 b$3.55 b$4.13 b
Growth43.99%16.51%18.42%
Q2, 2010Q3, 2010Q1, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019
Revenue$125.83 m$141.57 m$166.13 m$204.05 m$244.73 m$274.72 m$294.14 m$338.94 m$370.09 m$400.41 m$566.62 m$512.50 m$555.15 m$600.33 m$636.21 m$666.64 m$701.04 m$753.12 m$799.11 m$870 m$912 m$859 m$930.90 m$1.05 b$1.03 b$1.14 b$1.20 b$1.26 b

Annual Growth Rate (%)